Final 2009 Reports of Nationally Notifiable Infectious Diseases

August 2010
MMWR: Morbidity & Mortality Weekly Report;8/20/2010, Vol. 59 Issue 32, p1025
The article focuses on finalized data from the National Notifiable Diseases Surveillance System (NNDSS) in the U.S. for 2009, as of June 30, 2010. Initial tables do not include such diseases as diphtheria and yellow fever because no cases of these diseases were reported in the country during 2009. It notes that the website of the NNDSS is updated every year to include the latest national surveillance case definitions approved by the Council of State and Territorial Epidemiologists for enumerating data on nationally notifiable infectious diseases.


Related Articles

  • Infected areas as at 29 January 1999.  // Weekly Epidemiological Record;1/29/99, Vol. 74 Issue 4, p29 

    Presents a list of areas infected with communicable diseases. Prevalence of plague in Zaire; Detection of cholera in Angola; Outbreak of yellow fever in Bolivia.

  • Infected area as at 15 July 1999.  // Weekly Epidemiological Record;7/16/99, Vol. 74 Issue 28, p233 

    Presents a list of areas infected by communicable diseases as of July 1999. Occurrence of plague in Zaire; Outbreak of cholera in Angola; Detection of yellow fever in Brazil.

  • OUTBREAK NEWS.  // Weekly Epidemiological Record;1/25/2002, Vol. 77 Issue 4, p25 

    Presents news briefs on communicable diseases, as of January 2002. Total number of meningococcal disease in Somalia reported by the Ministry of Health since the outbreak began in October 2001; Estimated number of suspected cases of tularemia in Kosovo, Serbia according to the Institute of...

  • Yellow Fever Vaccine.  // Annals of Internal Medicine;Apr84, Vol. 100 Issue 4, p540 

    Presents an update of the 1978 Immunization Advisory Committee recommendations on yellow fever vaccine. Forms of epidemiologically distinguishable yellow fever; Precautions and contraindications in using yellow fever vaccines; Guidelines for the storage of the vaccine.

  • Infected areas as at 9 November 2000.  // Weekly Epidemiological Record;11/10/2000, Vol. 75 Issue 45, p366 

    Presents the compiled list of infected areas in Africa as of November 2000. Prevalence of plague, cholera and yellow fever; Affected areas due to cholera; Provinces affected by yellow fever under Angola.

  • Isolations of yellow fever virus from Haemagogus leucocelaenus in Rio Grande do Sul State, Brazil. Vasconcelos, Pedro F.C.; Sperb, AlethĂ©a F.; Monteiro, Hamilton A.O.; Torres, Maria A.N.; Sousa, Maria R.S.; Vasconcelos, Helena B.; Mardini, LĂșcia B.L.F.; Rodrigues, Sueli G. // Transactions of the Royal Society of Tropical Medicine & Hygiene;Jan2003, Vol. 97 Issue 1, p60 

    Following howling monkey (Alouatta caraya) deaths and yellow fever (YF) antigen detection by immunohistochemistry in the liver sample of a dead monkey in April and May 2001 in the municipalities of Garruchos and Santo Antonio das Missfies, Rio Grande do Sul State, Brazil, epidemiological field...

  • BOX 22-1 THE GOLDEN AGE OF MICROBIOLOGY. Scanlon, Valerie C.; Sanders, Tina // Essentials of Anatomy & Physiology;Jan2007, p498 

    Information on the golden age of microbiology from chapter 22 of the book "Essentials of Anatomy & Physiology" is presented. It presents a chronological time line of significant developments in microbiology between 1875 and 1900. This includes the discovery of the bacterium that causes anthrax...

  • Yellow fever: readily prevented but difficult to treat. Weir, Erica; Haider, Shariq // CMAJ: Canadian Medical Association Journal;6/22/2004, Vol. 170 Issue 13, p1909 

    Provides information on yellow fever. Background and epidemiology of the disease in South America and Africa; Use of an enzyme-linked immunosorbent assay method in the diagnosis of the disease; Discussion on yellow fever vaccine for the prevention of the disease.

  • Update on progress controlling yellow fever in Africa, 2004--2008.  // Weekly Epidemiological Record;12/12/2008, Vol. 83 Issue 50, p450 

    The article focuses on the progress of controlling yellow fever in Africa. It mentions that the Global Alliance for Vaccines and Immunization (GAVI) invested $58 million to decrease the risk of yellow fever in 12 countries in Africa. It discusses the case-based surveillance, a control strategy...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics